There are over 6,000 rare diseases affecting over 300 million people globally, and more than 90% of patients lack a viable treatment option. Diagnosing, treating and managing these complex and unpredictable conditions can be challenging for providers.
Today, forward-looking biopharma companies are developing digital solutions for rare diseases to help providers and patients diagnose, treat and manage rare diseases.
DIAGNOSIS
Because the conditions are so uncommon, providers often lack experience diagnosing patients with a rare disease. That means the road to diagnosis can be long—and frustrating. Patients may go years before receiving a diagnosis and getting the care they need.
DOSE MANAGEMENT & ADHERENCE
Depending on the disease, there can be quite a bit of trial and error to find the right treatment and dial in the right dose. Then, once it’s identified, patient adherence to their drug regimen is paramount—and not guaranteed.
DISEASE MANAGEMENT
Rare diseases are often lifelong chronic conditions that require complex and personalized treatments, as well as lifestyle modifications. And patients managing rare diseases often face geographic barriers to accessing care from providers who specialize in their condition.
CSL Behring’s patient population includes patients with rare and serious diseases. Many of our patients’ therapies are administered subcutaneously, requiring patients to take a very active role in administering and tracking their infusions. Improving treatment experiences through digital technology has been a focus for CSL Behring and is even more critical now during the ongoing global COVID-19 pandemic."
- Brian Johnson, Senior Director, Customer Engagement Management, CSL Behring
Powerful algorithms hosted on the BrightInsight Platform® give providers the insights they need to diagnose patients more quickly and accurately and match them with the right therapy as soon as possible.
We quickly and easily stand up patient-facing apps that help patients track symptoms and quality of life, keep track of medications, share information with their providers and schedule care when they need it.
Treatment selection algorithms can leverage vast patient- and population-level data sets to provide instant recommendations. And digital tools like dosing calculators can help prescribing physicians tailor treatments to maximize the therapeutic benefits.
The combination of a patient app and a robust clinician portal gives providers the valuable data they need to better manage a patient’s condition. Secure communication enables collaboration with other members of the care team.
Read how CSL Behring’s partnered with BrightInsight to launch an app for adult patients taking Hizentra for rare autoimmune disorders.
Read Now
Contact us to set up a demo today.
